Ossification, Heterotopic - 18 Studies Found
Recruiting |
: Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification : Ossification, Heterotopic : 2012-06-27 : Drug: Celecoxib 200 mg Q 12 hours orally Other Name: |
Completed |
: Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement : Ossification, Heterotopic : 2009-11-27 : Drug: Etoricoxib (Arcoxia) Oral intake of 90 mg Etoricoxib (Arcoxia) during 7-days |
Withdrawn |
: Study of Pamidronate for the Prevention of Heterotopic Ossification : Heterotopic Ossification : 2005-12-05 : Drug: Pamidronate (AREDIA) Pamidronate (AREDIA) vs radiation |
Withdrawn |
: Naproxen for the Prevention of HO After Complex Elbow Trauma : Heterotopic Ossification : 2007-12-14 : Drug: Naproxen 500 mg Naproxen twice a day for two weeks |
Active, not recruiting |
: Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy : Heterotopic Ossification : 2012-01-12 :
|
Recruiting |
: Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma : Elbow Trauma Requiring Operative Management : 2012-11-19 :
|
Completed |
: Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma : Elbow Fracture : 2009-10-07 : Radiation: Radiation Therapy (XRT) The dose will be 700 cGy in a single fraction, using AP-PA fields cal |
Active, not recruiting |
: An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France : Fibrodysplasia Ossificans Progressiva : 2016-11-23 :
|
Recruiting |
: ESWT as a Treatment for Chronic NHO in TBI Patients : TBI Traumatic Brain Injury : 2014-12-16 : Device: ESWT - Extracorporeal Shockwave Therapy Patients w |
Completed |
: Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™ :
|